Surmodics

VETEX Medical is an Irish medical device company developing a revolutionary thrombectomy catheter to speedily extract thrombus in a single session, from patients who present with Venous Thrombo-Embolism. Vetex Medical has developed the Vetex thrombectomy catheter as a platform technology for the venous vascular system targeting deep vein thrombosis, AV Fistula grafts and pulmonary embolism. Initially Vetex Medical will target patients with acute DVT in the ilio-femoral veins. The venous thrombectomy market has been underserved for many years but is currently one of the key drivers of the clot management market as clinical evidence and awareness increases.

NorMedix LLC is a design and development company specializing in medical device innovation, particularly in ultra-thin-walled, minimally invasive catheter technologies. The company provides a comprehensive range of services including idea generation, product innovation, and regulatory strategies. Its product development capabilities encompass design engineering, prototyping, and project management, ensuring that devices are both functional and manufacturable. NorMedix also offers verification and validation services, such as design characterization testing and clinical research, to ensure the efficacy and safety of its products. Additionally, the company handles manufacturing processes, including component fabrication, supply chain management, and clinical manufacturing. Among its portfolio are various advanced medical devices, including guide catheters, embolic protection devices, and vascular closure systems. Based in Plymouth, Minnesota, NorMedix operates as a subsidiary of SurModics, Inc.

Creagh Medical is an Irish manufacturing firm specializing in the design, development, and manufacture of angioplasty balloons.

BioFX Laboratories is a manufacturer of substrates, a critical component of diagnostic test kits used to detect and signal.

Brookwood Pharmaceuticals, Inc., a leading provider of drug delivery technology primarily to the pharmaceutical industry.

InnoRx, Inc., a development stage company, develops novel therapies for the ophthalmology market. The company focuses on the development of drugs and drug delivery systems for ocular disease. Its products target age-related macular degeneration (AMD) and diabetic macular edema (DME).